Otsuka Pharmaceutical Europe has received an amended European Commission marketing [...]

Grifols has dosed the first participant in a Phase 3 [...]

ten23 health has obtained Good Manufacturing Practice (GMP) licences from [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Hemab Therapeutics has highlighted new clinical and preclinical data across [...]

Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]

BridgeBio has published results from its pivotal Phase 3 Propel [...]

The European Commission has granted orphan drug designation to Chiesi [...]

GlobalData has identified Takeda’s oveporexton FDA decision as one of [...]

China’s approval of a first dual BAFF/APRIL therapy in IgA [...]